Internal Medicine, Medical Oncology · West Harrison, NY
NPI
1811156052
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
500 Westchester Ave
West Harrison, NY, 10604
Phone (914) 367-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
763 services
Medicare patients, 2024
232
Average age 75
Drug cost, 2024
$2.6M
388 prescriptions
Company payments, 2025
$2,865
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Parisa Momtaz was code 99215 (office e&m - established), 431 times for 191 patients. In total Parisa Momtaz billed 763 services in 9 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 431 | 191 | $130.14 | $56K |
| 99214 Office E&M - Established | Office | 250 | 145 | $93.11 | $23K |
| 99205 Office E&M - New | Office | 45 | 45 | $163.25 | $7,346 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 15 | $14.45 | $275 |
| 99213 Office E&M - Established | Office | 13 | 13 | $61.94 | $805 |
By year: 2022 $74K for 585 services; 2023 $85K for 740 services; 2024 $88K for 763 services.
Medicare prescription drug claims, 2024
In 2024, the drug Parisa Momtaz prescribed most often to Medicare patients was Braftovi (Encorafenib), with 44 prescriptions and refills. In total Parisa Momtaz wrote 388 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Braftovi Encorafenib | 44 | 44 | 11 | $664K |
| Mektovi Binimetinib | 44 | 44 | 11 | $650K |
| Prednisone Generic | 33 | 33 | 16 | $58.37 |
| Mekinist Trametinib Dimethyl Sulfoxide | 31 | 37 | Under 11 | $566K |
| Tafinlar Dabrafenib Mesylate | 30 | 36 | Under 11 | $424K |
| Pantoprazole Sodium Generic | 18 | 20 | Under 11 | $181 |
| Ondansetron Hcl Generic | 18 | 18 | 15 | $234 |
| Creon Lipase/Protease/Amylase | 13 | 18 | Under 11 | $17K |
| Zarxio Filgrastim-Sndz | 11 | 12 | Under 11 | $18K |
| Triamcinolone Acetonide Generic | 11 | 11 | 11 | $178 |
Brand drugs: 204 claims; generic drugs: 184 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Parisa Momtaz $2,865 ($2,865 in general payments such as food, travel and fees) from 2 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $2,865.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $2,865 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.